HIG
66
6
SLB
35
3
FSLR
47
-2
NKE
31
-2
SEE
55
5
BAX
50
2
SNA
53
3
MAC
55
4
UNP
40
2
NWSA
66
-2
ZION
65
4
LRCX
64
2
WM
68
-2
AMG
57
2
TGT
42
3
GOOG
73
8
SYF
62
7
DTE
47
2
NUE
47
3
EOG
46
14
HIG
66
6
SLB
35
3
FSLR
47
-2
NKE
31
-2
SEE
55
5
BAX
50
2
SNA
53
3
MAC
55
4
UNP
40
2
NWSA
66
-2
ZION
65
4
LRCX
64
2
WM
68
-2
AMG
57
2
TGT
42
3
GOOG
73
8
SYF
62
7
DTE
47
2
NUE
47
3
EOG
46
14
Financhill
Back

Apellis Pharmaceuticals Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
$19.28
Seasonality Move:
2.19%
Sell
35

REGN
Regeneron Pharmaceuticals

Last Price:
$493.14
Seasonality Move:
9%
Sell
48
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.28. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $493.22. The Score for REGN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.28
    The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $493.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 56.31 Buy
Chaikin Money Flow: -736195 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.94 - 19.02) Buy
Bollinger Bands (100): (18.38 - 27.78) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -26.26 Sell
Relative Strength Index (14 RSI): 34.64 Sell
Chaikin Money Flow: 157039 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (515.93 - 606.97) Sell
Bollinger Bands (100): (566.27 - 694.03) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.25 Buy
20-day SMA: 17.72 Buy
50-day SMA: 18.85 Buy
200-day SMA: 27.74 Sell
8-day EMA: 18.51 Buy
20-day EMA: 18.21 Buy
50-day EMA: 19.52 Sell
200-day EMA: 27.76 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 515.93 Sell
20-day SMA: 558 Sell
50-day SMA: 574.49 Sell
200-day SMA: 780.15 Sell
8-day EMA: 512.29 Sell
20-day EMA: 544.53 Sell
50-day EMA: 580.16 Sell
200-day EMA: 723.71 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.45 per share, a decrease next quarter of $0.16 per share, a decrease this year of $9.57 per share, and an increase next year of $4.76 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):